CHADS(2) and CHA(2)DS(2)-VASc Scores Can Guide the Evaluation of Cryptogenic Ischemic Stroke


EKİZOĞLU TURGUT E., Atmaca M. M., Cinar-Balcioglu C., YEŞİLOT N., ÇOBAN O.

NEUROLOGY INDIA, vol.69, no.6, pp.1716-1721, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 69 Issue: 6
  • Publication Date: 2021
  • Doi Number: 10.4103/0028-3886.333477
  • Journal Name: NEUROLOGY INDIA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.1716-1721
  • Keywords: CHADS(2), CHA(2)DS(2)-VASc, cryptogenic stroke, INCIDENT ATRIAL-FIBRILLATION, UNDETERMINED SOURCE, EMBOLIC STROKE, RISK STRATIFICATION, PREVENTION, MANAGEMENT, PREDICT
  • Istanbul University Affiliated: Yes

Abstract

Background and Aims: Cryptogenic ischemic strokes (CIS) are treated with antiplatelets for stroke prevention in routine clinical practice. The objective of this study was to investigate whether the CHADS(2) and CHA(2)DS(2)-VASc scores may be used to identify the patients with CIS at higher risk of ischemic stroke despite antiplatelet therapy.